Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Assets: 2014-2024

Historic Assets for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2024 value amounting to $235.4 million.

  • KalVista Pharmaceuticals' Assets was N/A to $294.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $294.8 million, marking a year-over-year change of. This contributed to the annual value of $235.4 million for FY2024, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Assets stood at $235.4 million for FY2024, which was up 154.41% from $92.5 million recorded in FY2020.
  • Over the past 5 years, KalVista Pharmaceuticals' Assets peaked at $235.4 million during FY2024, and registered a low of $92.5 million during FY2020.
  • Its 1-year average for Assets is $235.4 million, with a median of $235.4 million in 2024.
  • Data for KalVista Pharmaceuticals' Assets shows a maximum YoY declined of 21.67% (in 2020) over the last 5 years.
  • Over the past 2 years, KalVista Pharmaceuticals' Assets (Yearly) stood at $92.5 million in 2020, then followed by $235.4 million in 2024.